Teleflex is launching new products, acquiring Biotronik’s vascular unit, and splitting into two companies to reignite growth.

Background Benign multiple sclerosis (MS), characterised by minimal disability despite long disease duration, remains poorly understood in terms of its determinants and prognostic implications. While ...

Continuous glucose monitors are popular among non-diabetic people who want to track their blood sugar. Do CGMs help with weight loss? Experts discuss the benefits and downsides.

AI can help healthcare organizations bolster patient-centered care by flagging potential supply chain disruptions, GHX's ...

Against a backdrop of rising costs, workforce shortages and fragmented care, the Oracle Health and Life Sciences Summit convened leaders who are tackling these challenges head-on. Among the most ...

A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes ...

The Endocrine Society released a clinical practice guideline for the screening, diagnosis, and treatment of primary aldosteronism.

We read with great interest the Article by Shawn D St Peter and colleagues1 showing that an antibiotics-first approach in children with uncomplicated appendicitis is inferior to appendicectomy in ...

Revolution Medicines, Inc. shares surged on strong Phase 1 data for daraxonrasib in metastatic pancreatic cancer. Click here ...

A minimally invasive procedure with medical management was nonsuperior to medical management alone at 180 days in a cohort of ...

The upcoming meeting of the European Association for the Study of Diabetes will feature results from clinical trials in types 1 and 2 diabetes and obesity and new clinical practice guidelines.

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease – ...